They did, however, determine that increased numbers of CD206+ TAMs were linked to tumor aggressiveness, defined by the total tumor numbers, tumor-node-metastasis, poor overall survival, and recurrence, contradicting the results found in breast cancer studies [21]. This evidence concerns the gene MRC1 and neoplasm.